Is UCB (EBR:UCB) A Risky Investment?
Dec 24
Have your own idea? Try our Stock Screener
Belgian (BEL20) Healthcare Sector Analysis
UpdatedJan 21, 2025
DataAggregated Company Financials
Companies13
- 7D-2.7%
- 3M12.8%
- 1Y96.3%
- YTD-0.06%
Over the last 7 days, the Healthcare industry has dropped 2.7%, driven by UCB declining 4.2%. In contrast, Fagron has gained 9.0%. This takes the industry's 12 month performance to a gain of 96%. Looking forward, earnings are forecast to grow by 35% annually.
Sector Valuation and Performance
Has the Belgian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 22 Jan 2025 | €81.9b | €9.8b | €270.0m | 59.3x | 303.4x | 8.4x |
| Fri, 20 Dec 2024 | €79.7b | €9.8b | €269.9m | 58.1x | 295.2x | 8.2x |
| Sun, 17 Nov 2024 | €72.1b | €9.7b | €270.5m | 55.8x | 266.6x | 7.4x |
| Tue, 15 Oct 2024 | €70.2b | €9.4b | €130.2m | 62.1x | 538.9x | 7.4x |
| Thu, 12 Sep 2024 | €68.1b | €9.4b | €95.1m | 53.3x | 716.6x | 7.2x |
| Sat, 10 Aug 2024 | €66.7b | €9.4b | €59.4m | 57.9x | 1122.6x | 7.1x |
| Mon, 08 Jul 2024 | €58.5b | €8.9b | €37.9m | 53.9x | 1542.5x | 6.6x |
| Wed, 05 Jun 2024 | €52.2b | €8.9b | €38.9m | 49.8x | 1341.5x | 5.9x |
| Fri, 03 May 2024 | €51.6b | €8.8b | €60.0m | 48.1x | 860x | 5.9x |
| Sun, 31 Mar 2024 | €50.2b | €8.7b | €39.6m | 45.4x | 1266.5x | 5.7x |
| Tue, 27 Feb 2024 | €46.8b | €9.1b | -€82,517,547.20 | 41.7x | -567.7x | 5.1x |
| Thu, 25 Jan 2024 | €42.2b | €9.1b | -€125,983,766.00 | 39.6x | -335.3x | 4.6x |
| Sat, 23 Dec 2023 | €40.3b | €9.1b | -€123,474,648.00 | 37.6x | -326.3x | 4.4x |
| Mon, 20 Nov 2023 | €45.2b | €9.1b | -€121,748,725.00 | 32.6x | -371.1x | 5x |
| Wed, 18 Oct 2023 | €48.3b | €9.0b | -€304,410,823.00 | 34.8x | -158.6x | 5.4x |
| Fri, 15 Sep 2023 | €50.3b | €9.0b | -€360,992,103.00 | 35.4x | -139.2x | 5.6x |
| Sun, 13 Aug 2023 | €48.3b | €9.0b | -€338,350,864.00 | 41.4x | -142.8x | 5.4x |
| Tue, 11 Jul 2023 | €40.4b | €9.1b | -€346,576,903.00 | 35.8x | -116.6x | 4.4x |
| Thu, 08 Jun 2023 | €42.8b | €9.1b | -€360,545,953.00 | 38x | -118.6x | 4.7x |
| Sat, 06 May 2023 | €42.4b | €9.1b | -€84,608,961.00 | 27.5x | -500.6x | 4.7x |
| Mon, 03 Apr 2023 | €41.0b | €8.9b | -€275,709,873.00 | 26.8x | -148.6x | 4.6x |
| Wed, 01 Mar 2023 | €40.9b | €8.7b | -€333,940,867.00 | 26.4x | -122.5x | 4.7x |
| Fri, 27 Jan 2023 | €40.0b | €9.0b | €127.4m | 15.3x | 314x | 4.4x |
| Sun, 25 Dec 2022 | €40.0b | €9.0b | €111.6m | 14.9x | 358.5x | 4.4x |
| Tue, 22 Nov 2022 | €41.0b | €9.0b | €79.5m | 14.7x | 515.6x | 4.5x |
| Thu, 20 Oct 2022 | €41.1b | €8.9b | €48.8m | 13.9x | 841.1x | 4.6x |
| Sat, 17 Sep 2022 | €40.4b | €8.8b | €51.4m | 14.4x | 785.8x | 4.6x |
| Mon, 15 Aug 2022 | €40.7b | €8.8b | €193.9m | 15.1x | 209.7x | 4.6x |
| Wed, 13 Jul 2022 | €41.9b | €8.9b | €645.1m | 16.7x | 64.9x | 4.7x |
| Fri, 10 Jun 2022 | €40.1b | €8.9b | €617.0m | 17.3x | 65x | 4.5x |
| Sun, 08 May 2022 | €43.1b | €8.8b | €646.1m | 19.5x | 66.7x | 4.9x |
| Tue, 05 Apr 2022 | €44.5b | €9.0b | €839.7m | 19.8x | 52.9x | 5x |
| Thu, 03 Mar 2022 | €40.4b | €8.7b | €810.6m | 15.4x | 49.8x | 4.7x |
| Sat, 29 Jan 2022 | €36.6b | €8.6b | €732.1m | 14.6x | 50x | 4.2x |
Price to Earnings Ratio
50x
Current Industry PE
- Investors are optimistic on the Belgian Healthcare industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 303x which is higher than its 3-year average PE of 281x.
- The 3-year average PS ratio of 5.4x is lower than the industry's current PS ratio of 8.4x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 28% per year over the last three years.
- Meanwhile revenues for these companies have grown 4.1% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Belgian Healthcare sector?
| BE Market | 1.97% | |
| Healthcare | -2.72% | |
| Healthtech | 11.59% | |
| Healthcare Services | 9.02% | |
| Medical Equipment | 2.95% | |
| Life Sciences | 0% | 0 |
| Biotech | -1.92% | |
| Pharma | -3.94% | |
Industry PE
- Investors are most optimistic about the Pharma industry which is trading above its 3-year average PE ratio of 50.3x.
- Analysts are expecting annual earnings growth of 28.2%, which is lower than the prior year's growth of 77.8% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 113% over the next 5 years.
- In contrast, the Healthcare Services industry is expected to see its earnings grow by 14% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| FAGR Fagron | €18.14 | 8.6% +€105.1m | 7.5% | PE17x | |
| NYXH Nyxoah | €10.45 | 15.3% +€52.0m | 108.2% | PS76.9x | |
| AGFB Agfa-Gevaert | €0.76 | 7.2% +€7.9m | -34.8% | PS0.1x |
